Sep 16, 2024 7:30am EDT Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from Ó£ÌÒÊÓƵ
Aug 07, 2024 4:06pm EDT Ó£ÌÒÊÓƵ Reports Second Quarter 2024 Business Highlights and Financial Results
Jul 17, 2024 4:14pm EDT Ó£ÌÒÊÓƵ and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
May 07, 2024 4:05pm EDT Ó£ÌÒÊÓƵ Reports First Quarter 2024 Business Highlights and Financial Results
Mar 28, 2024 8:55am EDT Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics Business
Mar 05, 2024 8:52am EST AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV